Title
The Peru Cervical Cancer Prevention Study (PERCAPS): The technology to make screening accessible
Date Issued
01 May 2013
Access level
open access
Resource Type
journal article
Author(s)
Levinson K.L.
Abuelo C.
Salmeron J.
Chyung E.
Zou J.
Belinson S.E.
Wang G.
Santos C.
Belinson J.L.
Abstract
Objective: This study utilized a combination of HPV self-sampling, iFTA elute specimen cards, and long distance transport for centralized processing of specimens to determine the feasibility of large-scale screening in remote and transient populations. Methods: This study was performed in two locations in Peru (Manchay and Iquitos). The "Just For Me" cervico-vaginal brush and iFTA elute cards were used for the collection and transport of specimens. Samples were shipped via FedEx to China and tested for 14 types of high-risk HPV using PCR based MALDI-TOF. HPV positive women were treated with cryotherapy after VIA triage, and followed-up with colposcopy, biopsy, ECC, and repeat HPV testing at 6 months. Results: Six hundred and forty three women registered, and 632 returned a sample over a 10 day period. Within 2 weeks, specimens were shipped, samples tested, and results received by study staff. Sixty-eight women (10.8%) tested positive, and these results were delivered over 4 days. Fifty-nine HPV positive women (87%) returned for evaluation and treatment, and 2 had large lesions not suitable for cryotherapy. At 6 months, 42 women (74%) returned for follow-up, and 3 had CIN 2 (all positive samples from the endocervical canal). Ninety eight percent of participants reported that they would participate in this type of program again. Conclusions: Utilizing HPV self-sampling, solid media specimen cards for long distance transport, and centralized high throughput processing, we achieved rapid delivery of results, high satisfaction levels, and low loss to follow-up for cervical cancer screening in remote and transient populations. © 2013 Elsevier Inc. All rights reserved.
Start page
318
End page
323
Volume
129
Issue
2
Language
English
OCDE Knowledge area
Patología Obstetricia, Ginecología
Scopus EID
2-s2.0-84876286094
PubMed ID
Source
Gynecologic Oncology
ISSN of the container
10956859
Sponsor(s)
English Translation: National Institute of Neoplastic Diseases. the Peruvian NIH, and the Cleveland Clinic. The projects were registered with the US National Institutes of Health as number NCT01338051. Funding for the projects was obtained through the Merck Inc. “Investigator Initiated Studies Program”, Preventive Oncology International, and the NIH Fogarty Fellowship Program.
Sources of information: Directorio de Producción Científica Scopus